---
figid: PMC11758981__fmicb-15-1520252-g001
figtitle: Gut microbial regulation of lipids reflects the influence of gut microbiota
  on hyperlipidemia in various treatment methods
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11758981
filename: fmicb-15-1520252-g001.jpg
figlink: /pmc/articles/PMC11758981/figure/F1/
number: F1
caption: 'Mechanisms of gut microbial regulation of lipids reflects the influence
  of gut microbiota on hyperlipidemia in various treatment methods. Among them, gut
  microbiota regulates BAs from several aspects: dissociation, 7-dehydroxylation reaction,
  oxidation and isomerization, and microbial coupling of bile acids. The gut microbiota
  increases cholesterol utilization in the blood through pathways such as AMPK/PPAR
  by affecting the generation of SCFAs, while inhibiting liver cholesterol synthesis.
  Intestinal microbiota can inhibit LPL and regulate dyslipidemia by regulating fiaf
  factors and ANGPTL 3, 4, 8. SCFAs, short-chain fatty acids AMPK signaling pathway:adenosine
  monophosphate-dependent protein kinase-mediated signaling pathway PPAR signaling
  pathway:peroxisome proliferator-activated receptor-mediated signaling pathway; BAs,
  bile acids; BSH, bile salt hydrolases; ANGPTL, angiotensin proteins fiaf factor:fasting-induced
  adipokines; LPL, lipoprotein lipase'
papertitle: Hyperlipidaemia treatment and gut microbiology
reftext: Liu Zhe, et al. Front Microbiol. 2024;15(NA).
year: '2024'
doi: 10.3389/fmicb.2024.1520252
journal_title: Frontiers in Microbiology
journal_nlm_ta: Front Microbiol
publisher_name: Frontiers Media SA
keywords: hyperlipidaemia | gut microbiota | gut flora | treatment | mechanisms
automl_pathway: 0.9531309
figid_alias: PMC11758981__F1
figtype: Figure
redirect_from: /figures/PMC11758981__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11758981__fmicb-15-1520252-g001.html
  '@type': Dataset
  description: 'Mechanisms of gut microbial regulation of lipids reflects the influence
    of gut microbiota on hyperlipidemia in various treatment methods. Among them,
    gut microbiota regulates BAs from several aspects: dissociation, 7-dehydroxylation
    reaction, oxidation and isomerization, and microbial coupling of bile acids. The
    gut microbiota increases cholesterol utilization in the blood through pathways
    such as AMPK/PPAR by affecting the generation of SCFAs, while inhibiting liver
    cholesterol synthesis. Intestinal microbiota can inhibit LPL and regulate dyslipidemia
    by regulating fiaf factors and ANGPTL 3, 4, 8. SCFAs, short-chain fatty acids
    AMPK signaling pathway:adenosine monophosphate-dependent protein kinase-mediated
    signaling pathway PPAR signaling pathway:peroxisome proliferator-activated receptor-mediated
    signaling pathway; BAs, bile acids; BSH, bile salt hydrolases; ANGPTL, angiotensin
    proteins fiaf factor:fasting-induced adipokines; LPL, lipoprotein lipase'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPTL3
  - ANGPTL4
  - BAS
  - LPL
  - LCP1
  - ANGPTL8
  - PPARA
  - PPARD
  - PPARG
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - BSH
  - BAS
  - triglyceride
  - SCFAs
  - cholesterol
---
